What is the normal inspiratory time (i‑time) on BiPAP for most adult patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Inspiratory Time on BiPAP

The default and recommended initial inspiratory time (i-time) on BiPAP is 1.2 seconds, with a target %IPAP time of 30-40% of the respiratory cycle. 1

Initial Settings

The American Academy of Sleep Medicine consensus guidelines provide clear starting parameters for BiPAP inspiratory time:

  • Default i-time: 1.2 seconds (this is the standard factory setting on most NPPV devices) 1
  • Target %IPAP time: 30-40% of the total cycle time 1
  • At a respiratory rate of 15 breaths/minute, this translates to an i-time range of 1.2-1.6 seconds 1

The %IPAP time is calculated as: (Inspiratory time × 100) / Cycle time, where cycle time = 60 seconds / respiratory rate.

Disease-Specific Adjustments

The i-time should be tailored based on underlying pathophysiology:

Obstructive Lung Disease (COPD, Asthma)

  • Use shorter i-time (~30% IPAP time) 1
  • This allows adequate expiratory time since these patients have prolonged expiratory flow limitation
  • Maintains appropriate I:E ratio (minimum 1:2) to prevent air trapping 1

Restrictive Lung Disease

  • Use longer i-time (~40% IPAP time) 1
  • Decreased respiratory system compliance requires more time to deliver adequate tidal volume
  • The longer inspiratory phase compensates for reduced lung/chest wall compliance 1

Practical Application Algorithm

When setting i-time, follow this sequence:

  1. Start with 1.2 seconds as your default 1

  2. Calculate your target based on respiratory rate:

    • At RR 10: i-time 1.8 sec (30%) to 2.4 sec (40%)
    • At RR 12: i-time 1.5 sec (30%) to 2.0 sec (40%)
    • At RR 15: i-time 1.2 sec (30%) to 1.6 sec (40%)
    • At RR 20: i-time 0.9 sec (30%) to 1.2 sec (40%) 1
  3. Adjust based on clinical response:

    • Titrate to maximize ventilation, patient-ventilator synchrony, and comfort 1
    • Monitor tidal volume delivery
    • Assess for patient comfort and tolerance

Critical Considerations

Common pitfalls to avoid:

  • Don't use excessively long i-times with obstructive disease - this prevents adequate exhalation and can worsen dynamic hyperinflation and patient discomfort 1

  • As respiratory rate increases, i-time must decrease to maintain adequate I:E ratio 1

  • The minimum I:E ratio should be 1:2, with longer exhalation times preferred for obstructive lung disease 1

  • In ST (spontaneous-timed) or timed modes, both respiratory rate and i-time must be specified for machine-triggered breaths, though devices have default values 1

The i-time setting directly impacts tidal volume delivery, patient synchrony, and overall ventilation effectiveness, making it a critical parameter that requires individualized adjustment beyond the initial 1.2-second default based on the patient's underlying respiratory mechanics and clinical response.

References

Guideline

best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (nppv) in stable chronic alveolar hypoventilation syndromes.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Related Questions

In a 9‑week‑old infant with subfebrile temperature (maximum 37.8 °C), rhinorrhea, cough, a single post‑cough vomiting episode, inconsolable crying with transient abdominal tenderness that resolves when the infant stops crying, and normal stooling, what is the best management approach?
After percutaneous coronary catheterisation (PCCC), how is the arterial puncture closed?
What is the appropriate treatment for a 25‑year‑old woman with malodorous leukorrhea?
What is the appropriate workup and treatment for a 75-year-old woman with acute swollen fingers limiting movement?
Are there lymph nodes located on the flank above the hip?
What antihypertensive medication can both lower blood pressure and help reduce anxiety in a patient who is very anxious after a HIDA scan performed over three months ago and is currently taking valsartan and hydrochlorothiazide?
What are the symptoms of kidney cancer?
What labs and clinical parameters should be monitored in a patient on chronic phenobarbital therapy?
For an adult patient with metastatic hormone‑sensitive prostate cancer in 2026, is oral relugolix (Orgovyx) or injectable leuprolide (Lupron) the preferred first‑line androgen‑deprivation therapy?
How should I manage a patient with normal CBC and chemistry but borderline low iron studies (low serum iron, normal TIBC, transferrin saturation 18%, ferritin 33 ng/mL) and vitamin D deficiency (25‑OH‑vitamin D 18 ng/mL)?
What is the appropriate glycerin suppository dose for a healthy 6‑month‑old infant with constipation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.